Pinealon is a synthetic tripeptide composed of the amino acids L-glutamic acid, L-aspartic acid, and L-arginine, with the sequence Glu-Asp-Arg (EDR). This peptide has garnered attention for its purported geroprotective properties, particularly in the Russian scientific literature. Research indicates that Pinealon can protect rat offspring from prenatal hyperhomocysteinemia, leading to improved postnatal cognitive function. Additionally, it has been shown to maintain learning retention in rats with experimentally-induced diabetes and enhance cognitive performance in both older adults and young athletes.
Pinealon’s neuroprotective effects are attributed to its ability to prevent the accumulation of reactive oxygen species (ROS) and suppress the activation of ERK 1/2, thereby stimulating the functional activity of brain tissue cells and reducing spontaneous cell death.
Beyond its neuroprotective qualities, Pinealon interacts directly with DNA, bypassing traditional receptor pathways, which explains its wide-ranging effects. It has been linked to behavior modification, circadian rhythm regulation, and potential applications in treating cognitive disorders like Alzheimer’s disease. Furthermore, Pinealon boosts the expression of irisin, a hormone associated with fat burning and telomere elongation, suggesting broader anti-aging benefits.
Pinealon’s ability to modulate the cell cycle and reduce caspase-3 levels, a key enzyme in apoptosis, highlights its potential in treating conditions like ischemic stroke and myocardial infarction. It also shows promise in skin cell regeneration, making it a candidate for wound healing and anti-aging skincare.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.